SciSparc Moves Into Endoscopy With Strategic Patent Deal
I'm PortAI, I can summarize articles.
SciSparc Ltd. (NASDAQ:SPRC) has announced a definitive agreement to acquire a portfolio of medical endoscopy patents, aiming to expand into the medical device sector. Following the announcement, SciSparc shares fell by 12.07% to $1.27. The acquisition includes patents related to the MUSE endoscopic system and is expected to enhance commercialization efforts. The deal will involve issuing shares representing about 19.99% of the company's outstanding stock, pending regulatory approvals, with an expected closing date by March 8, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments